SOM INNOVATION BIOTECH SA
🇪🇸Spain
Efficacy and Safety on SOM3355 in Huntington's Disease Chorea
Phase 2
Active, not recruiting
- Conditions
- Huntington Chorea
- Interventions
- Drug: SOM3355 capsulesDrug: Placebo capsules
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 129
- Registration Number
- NCT05475483
- Locations
- 🇫🇷
Hopital de Hautepierre, Strasbourg, France
🇫🇷Hôpital Purpan - CHU Toulouse, Toulouse, France
🇮🇹IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
Efficacy and Safety of SOM3355 in Huntington's Disease Chorea
Phase 2
Completed
- Conditions
- Huntington's Chorea
- Interventions
- Drug: SOM3355 100mg BIDDrug: SOM3355 200mg BIDDrug: Placebo BID
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 32
- Registration Number
- NCT03575676
- Locations
- 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain
🇪🇸Hospital ClÃnic de Barcelona, Barcelona, Spain
Study of SOM0226 in Familial Amyloid Polyneuropathy
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- SOM Innovation Biotech SA
- Target Recruit Count
- 17
- Registration Number
- NCT02191826
- Locations
- 🇪🇸
Hospital Vall d'Hebron, Barcelona, Catalonia, Spain
© Copyright 2025. All Rights Reserved by MedPath